Suchergebnisse - "Sarilumab"

PubPharm (319)

51

A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis

in: Arthritis Research & Therapy | 2023

von Wolfgang A. Schmidt | Bhaskar Dasgupta | Jennifer Sloane | +13

52

Impact of IL6R genetic variants on treatment efficacy and toxicity response to sarilumab in rheumatoid arthritis

in: Arthritis Research & Therapy | 2023

von Luis Sainz | Pau Riera | Patricia Moya | +7

53

Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19 : a systematic review and meta-analysis

enthalten in: Emerging microbes & infections | 2022

von Yu, S. | Koh, D. | Choi, M. | +4

54

Drug-induced liver injury following the use of tocilizumab or sarilumab in patients with coronavirus disease 2019

enthalten in: BMC infectious diseases | 2022

von Gao, Q. | Yin, X. | Tan, B. | +5

55

Drug-induced liver injury following the use of tocilizumab or sarilumab in patients with coronavirus disease 2019

enthalten in: BMC infectious diseases | 2022

von Gao, Q. | Yin, X. | Tan, B. | +5

56

Drug-induced liver injury following the use of tocilizumab or sarilumab in patients with coronavirus disease 2019

enthalten in: BMC infectious diseases | 2022

von Gao, Q. | Yin, X. | Tan, B. | +5

57

Anti-Interleukins for Severe Coronavirus Disease-2019 : Hype or Hope?

enthalten in: Mediterranean journal of rheumatology | 2022

von Dimosiari, A. | Patoulias, D. | Makris, D.

58

Severe coronavirus disease 2019 in a patient with TAFRO syndrome : A case report

enthalten in: Clinical infection in practice | 2022

von Oshima, K. | Kanamori, H. | Takei, K. | +2

59

Correspondence on : 'Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation-an open-label cohort study' by Della-Torre et al

enthalten in: Annals of the rheumatic diseases | 2022

von Cheng, C. | Zhang, F.

CommentOn: Ann Rheum Dis. 2020 Oct;79(10):1277-1285. - PMID 32620597

60

Impact of sarilumab on mechanical ventilation in patients with COVID-19. Response to : 'Correspondence on: 'Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation-an open-label cohort study' by Della-Torre et al' by Cheng and Zhang

enthalten in: Annals of the rheumatic diseases | 2022

von Della-Torre, E. | Landoni, G. | Zangrillo, A. | +1

CommentOn: Ann Rheum Dis. 2020 Oct;79(10):1277-1285. - PMID 32620597